TVTX
NASDAQ · Biotechnology
Travere Therapeutics Inc
$48.97
-3.45 (-6.58%)
Analyst Consensus
Strong Buy
21
Analysts
High
Coverage
Price Target
Analyst Price Target
-24.1% upside
Low Target
$26.93
Average Target
$37.15
High Target
$48.45
Current Price
$48.97
Current
$48.97
$48.97
Target
$37.15
$37.15
$26.93
$37.15 avg
$48.45
Scenario Analysis
Bear Case
$26.93
-45.0%
Low target
Base Case
$37.15
-24.1%
Avg target
Bull Case
$48.45
+-1.1%
High target
Risk/Reward
0.0x
Unfavorable
Price in Context
52-Week High
$68.73
-28.8% from high
52-Week Low
$22.59
+116.8% from low
50-Day SMA
$58.12
-15.7% vs SMA
200-Day SMA
$46.95
+4.3% vs SMA
RSI (14)
48.7
Neutral
Target vs 52W High
$37.15
-45.9% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +115.6% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -42.4% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.4% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.8% |